ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2023

November 10-15, 2023. San Diego, CA.

View by Number View by Title View Sessions
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1596
    A Cell and Transcriptomic Atlas of the Infrapatellar Fat Pad from Patients with Knee Osteoarthritis: Identification of an Obesity-Associated Transcriptomic Signature
  • Abstract Number: 0589
    A Comparative Evaluation of IgA2 Anti-dsDNA Antibodies and Clinical Outcome in Two Clinical Trials of Belimumab After Rituximab in SLE
  • Abstract Number: 1148
    A Comparative Study of Clinical Phenotype in Relation to NOD2 Sub-genotypes in Yao Syndrome
  • Abstract Number: 1150
    A Comparative Study of Cryofibrinogenemia Before and After COVID-19 Era
  • Abstract Number: 1471
    A Comparative Study of Lupus Nephritis Class II and IgA Nephropathy: Renal Disease Other Than Lupus Nephritis in Systemic Lupus Erythematosus Patients
  • Abstract Number: 0487
    A Comparative Study of Serositis Between Inpatients with Psoriatic Arthritis and Rheumatoid Arthritis
  • Abstract Number: 1100
    A Comparison of Characteristics of Patients with Crystalline and Septic Arthritis Confirmed by Synovial Fluid Analysis: Towards the Development of a Diagnostic Rule
  • Abstract Number: 1067
    A Comparison of Joint Involvement Patterns in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis and Rheumatoid Arthritis
  • Abstract Number: 1731
    A Competitive Inhibitor of MOART Showed Potent Therapeutic Effects in a Mouse Model of Collagen-induced Arthritis
  • Abstract Number: 0927
    A Complex Interplay Among Gut Lachnoclostidium, HLA Haplotype DRB1*07:01, and the TNF Superfamily in Anti-Ro+ Women with a Spectrum of Preclinical and Clinical Autoimmunity Whose Children Have Neonatal Lupus
  • Abstract Number: 0228
    A Comprehensive Retrospective Analysis of Polymyalgia Rheumatica in Long COVID Patients at an Academic Medical Center in the Midwest
  • Abstract Number: 0171
    A Conceptual Framework to Characterize the Indirect Burden of Systemic Lupus Erythematosus (SLE): Findings from Qualitative Patient Interviews
  • Abstract Number: 2473
    A Consensus Based Algorithm to Screen for Lung Disease in Children with Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 2071
    A Consensus Based Shoulder Examination for Rheumatology Training
  • Abstract Number: 2077
    A Curriculum of Online Education Significantly Improved Rheumatologists’ Knowledge, Competence and Confidence in Managing Patients with Spondyloarthritis
  • Abstract Number: 1398
    A Deep Learning Algorithm for MRI Spinal Inflammation in Axial Spondyloarthritis
  • Abstract Number: 1876
    A Deep Learning System for Automated Assessing Microcirculation Abnormalities in Nailfold Capillaroscopy Images of Systemic Sclerosis
  • Abstract Number: 0665
    A Descriptive Study of Disease Characterisics of SSc Patients with the U2RNP Autoantibody
  • Abstract Number: 1124
    A Double-blind, Placebo-parallel Controlled Phase III Clinical Study of the Efficacy and Safety of Hemay005 Tablets in Patients with Moderate to Severe Chronic Plaque Psoriasis in China
  • Abstract Number: 0738
    A Genome-wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome
  • Abstract Number: 0632
    A Longitudinal Analysis of Mouth Opening in 1101 Systemic Sclerosis Patients from the French National Cohort Study
  • Abstract Number: 1846
    A Longitudinal Study: The Benefits of Non-Pharmacological Approaches to Improve Self-Reported Pain, Stiffness, and Fatigue in Individuals with Musculoskeletal Disorders
  • Abstract Number: 2356
    A Macrophage-Specific Mechanism for Mycophenolate Mofetil in the Treatment of Systemic Sclerosis
  • Abstract Number: 2062
    A Mental Health Workshop for Pediatric Rheumatology Fellows
  • Abstract Number: 0274
    A Mix-and-match COVID-19 Vaccination Strategy in Patients with Rheumatic Diseases on Rituximab
  • Abstract Number: 0771
    A Modified Idiopathic Pulmonary Fibrosis-Derived Composite Biomarker Score Is Associated with Interstitial Lung Disease Among U.S. Veterans with Rheumatoid Arthritis
  • Abstract Number: 0430
    A Multicenter, Real-world Clinical Data Study of the Use of JAK Kinase Inhibitors in a Large Cohort of Patients with Rheumatoid Arthritis
  • Abstract Number: 1003
    A Multidisciplinary Obstetric-Medicine/Rheumatology Specialty Clinic in the United States: A Five Year Analysis
  • Abstract Number: 2067
    A New Tool Assessing Trainees’ Interventional Musculoskeletal Ultrasound Skills
  • Abstract Number: 1747
    A Newly Described Cytokine interleukin-40 Is Increased in the Serum of Individuals At-risk of Rheumatoid Arthritis and Induces an Inflammatory Response in Mononuclear Cells
  • Abstract Number: 0798
    A Novel 3D Model of Rheumatoid Arthritis Synovial Tissue Incorporating Fibroblasts, Endothelial Cells and Macrophages
  • Abstract Number: 0866
    A Novel 3D-Synovium-Immune Microenvironment Mimics Macrophage-Synovial Fibroblast Interactions in Inflammatory Arthropathies
  • Abstract Number: 0727
    A Novel Active Pemphigus Vulgaris Mouse Model Induced by Immunization with TLR Ligand Adjuvanted Recombinant Desmoglein 3 Protein Vaccine
  • Abstract Number: 1728
    A Novel Animal Model for Investigating the Effect of HLA-DRB1 on Atherosclerosis
  • Abstract Number: 2534
    A Novel Approach for Mixed-methods Research Using Language Learning Models: A Report Using Patients’ Perspectives on Barriers to Hip and Knee Replacement
  • Abstract Number: 0655
    A Novel Association Between Lipodermatosclerosis and Key Vascular Outcomes in Systemic Sclerosis
  • Abstract Number: 2586
    A Novel Blood-Based Assay Differentiates Seropositive and Seronegative Rheumatoid Arthritis from Healthy Individuals and Those with Other Inflammatory Diseases or Osteoarthritis
  • Abstract Number: 1779
    A Novel Inhibitory Pathway of Synovial Inflammation Exerted by Glucocorticoids and TNF Inhibitors Through LAG-3 Up-Regulation
  • Abstract Number: 0264
    A Novel Role for Rheumatologists: Managing Idiopathic Granulomatous Mastitis
  • Abstract Number: 0940
    A Novel Therapeutic Opportunity in Systemic Sclerosis: The Fibrolytic Activities of a Specialized Macrophage Secretome
  • Abstract Number: 0033
    A Novel Transcriptome-Based Machine Learning Pipeline Predicts Phenotypes of Lupus Patients
  • Abstract Number: 0030
    A Pathogenetic Model of IgG4-related Disease Developed from Familial IKZF1 and UBR4 Gene Variants
  • Abstract Number: 1083
    A Patient-Centered Approach to Increase Herpes Zoster Vaccination in Patients on Janus Kinase Inhibitors: A Fellowship Quality Improvement Initiative
  • Abstract Number: 1654
    A Peer Health Coached Resilience-Based Energy Management Program Was Effective in Improving Fatigue and Other Outcomes in People with Systemic Sclerosis: Results of a Randomized Controlled Trial
  • Abstract Number: 1191
    A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dosing, Ascending-Dose Study Evaluating the Safety, Tolerability and Pharmacokinetics of XG004 Applied Topically in Participants with Osteoarthritis of the Knee
  • Abstract Number: L19
    A Phase 3 Study of Repeat Injection of TLC599 in Osteoarthritis of the Knee: Benefits to 52 Weeks
  • Abstract Number: 1920
    A Phase Ib/II Randomized, Double-blind, Placebo-controlled Study of Novel anti-IL-17A Monoclonal Antibody JS005 in Patients with Moderate to Severe Psoriasis
  • Abstract Number: 2519
    A Phase II Clinical Study to Investigate the Efficacy and Safety of Hemay005 Tablets in Patients with Active Behçet`sDisease
  • Abstract Number: 0571
    A Polygenic Risk Score for Systemic Lupus Erythematosus (SLE) Discriminates Between Patients with Lupus and Individuals Without Lupus and a Positive Antinuclear Antibody Test
  • Abstract Number: 0700
    A Population-Based Study of Vasculitis Among Farmers and Urban Residents in Alberta
  • Abstract Number: 0010
    A Potential Mechanism for Major Adverse Cardiac Events Associated with JAK Inhibitors: JAK Inhibitor Withdrawal Causes Urokinase Release by Primed STAT Signaling
  • Abstract Number: 2583
    A Predictive Model for Progression to Clinical Arthritis Based on Lymphocyte Subsets and ACPA in At-risk Individuals with Arthralgia
  • Abstract Number: 0013
    A Proliferating T Cell Signature in Blood Is Associated with Response to JAK Inhibitor Therapy in Rheumatoid Arthritis Patients
  • Abstract Number: 1430
    A Proof-of-concept Study Evaluating the Use of Functional Brain Magnetic Resonance Imaging in Assessing Treatment Response in Psoriatic Arthritis Patients
  • Abstract Number: 1096
    A Quality Improvement Project About Medication Adherence to Understand What Questions Rheumatology Patients Have About Their Medications, and How They Answer Them
  • Abstract Number: 2055
    A Randomized Controlled Trial of Two Hepatitis a Vaccine Doses Among Adolescents with Juvenile Idiopathic Arthritis and Crohn’s Disease on Immunosuppressive Therapy: A Pilot Study
  • Abstract Number: 2595
    A Randomized Controlled Trial to Compare the Efficacy and Safety of Tacrolimus with Mycophenolate Mofetil in Patients with Systemic Sclerosis – Interstitial Lung Disease ( INSIST TRIAL)
  • Abstract Number: 1997
    A Randomized, Double-blind, Phase III Study to Compare SB16 (Proposed Denosumab Biosimilar) to Reference Denosumab in Patients with Postmenopausal Osteoporosis
  • Abstract Number: 0323
    A Randomized, Double-blind, Placebo-controlled, Repeat Injection, 52-Week Study to Evaluate the Efficacy and Safety of an Intra-articular Injection (IAI) of CNTX-4975-05 (CNTX) in Subjects with Chronic, Moderate-to-severe Osteoarthritis Knee Pain (MSOAKP) – Study 304
  • Abstract Number: 0324
    A Randomized, Double-blind, Placebo-controlled, Single Injection, 52-Week Study to Evaluate the Efficacy and Safety of an Intra-articular Injection (IAI) of CNTX-4975-05 (CNTX) in Subjects with Chronic, Moderate-to-severe Osteoarthritis Knee Pain (OAKP) – Study 301
  • Abstract Number: 0837
    A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis
  • Abstract Number: 2379
    A Real-World Descriptive Study of Renal Outcomes Among Patients with ANCA-Associated Vasculitis Initiating Remission Induction Therapy
  • Abstract Number: 0554
    A Refined Disease Activity Immune Index Informed by Select Immune Mediators That Characterizes Clinical Disease Activity in Systemic Lupus Erythematosus
  • Abstract Number: 2402
    A Retrospective Analysis of Prevalence of Positive Temporal Artery Biopsies in African American Patients with Giant Cell Arteritis (GCA) in a Large Academic Health Center
  • Abstract Number: 1142
    A Retrospective Analysis of Radiographic and Serologic Findings in Patients with Scleroderma and Interstitial Lung Disease
  • Abstract Number: 1531
    A Retrospective Analysis of the Efficacy of Nintedanib in Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD): A TriNetX Database Study
  • Abstract Number: 0786
    A Retrospective Analysis of the Efficacy of the Euro-Lupus Nephritis Cyclophosphamide Regimen versus NIH Regimen in a South Carolina Lupus Nephritis Cohort
  • Abstract Number: 0825
    A Revised Outcome Measure for Dermatomyositis Clinical Trials: The Dermatomyositis Outcomes for Muscle and Skin (DMOMS)
  • Abstract Number: 1125
    A Rheumatologic Clinical Profile of the VEXAS Syndrome: Results from a Survey Conducted Among Rheumatologic Units of 126 Hospitals Across Spain
  • Abstract Number: 1011
    A Rheumatology Model of Care Re-design: Integrating the Advanced Practice Provider
  • Abstract Number: 1940
    A Single-center, Observational, Retrospective, Case Control Study of Rituximab for the Treatment of Interstitial Pneumonia Associated with Autoimmune Features
  • Abstract Number: 0547
    A Spatially-resolved Single Cell Resolution Atlas of Pediatric Lupus Nephritis Uncovers Complex Interactions Between Stromal and Infiltrating Immune Cells
  • Abstract Number: 2401
    A Study Defining the Optimal Sonographic Parameters for Intima-Media Thickness in Diagnosing Giant Cell Arteritis
  • Abstract Number: 1835
    A Survey on Fibromyalgia-Related Knowledge Among Internal Medicine Residents
  • Abstract Number: 2085
    A Survey on Giant Cell Arteritis-Related Knowledge Among Internal Medicine Residents
  • Abstract Number: 0031
    A Systematic Approach for Identifying Causal Variants and Their Target Genes on JIA Risk Haplotypes
  • Abstract Number: 2211
    A Two-year Comparison of Back Pain and Morning Stiffness in Axial Spondyloarthritis and Non-axial Spondyloarthritis Chronic Back Pain Patients in the Spondyloarthritis Caught Early (SPACE) Cohort
  • Abstract Number: 1366
    A Unique Cluster of Inflammatory Monocytes and Functionally Intact Regulatory T Cells in Rare Childhood Sjögren’s Disease
  • Abstract Number: 0082
    A VAV1-Directed Molecular Glue Degrader, MRT-6160, Reduces Joint Inflammation in a Collagen-Induced Arthritis Autoimmune Disease Model
  • Abstract Number: 1184
    A Wearable-Sensor for Assessment of Gait and Chair Stand Patterns in People with Knee Osteoarthritis: Validation and Responsiveness to Treatment of a Potential Digital Biomarker
  • Abstract Number: 0835
    Abatacept in Individuals at Risk of Developing Rheumatoid Arthritis: Results from the Arthritis Prevention in the Pre-clinical Phase of RA with Abatacept (APIPPRA) Trial
  • Abstract Number: 1318
    Abatacept Modulates Both Global and Citrulline Specific T Cell Signatures: Results from Inhibition of Co-Simulation in Rheumatoid Arthritis Phase IV Trial
  • Abstract Number: 1556
    Abdominal Surgical Interventions Among Patients with Gastrointestinal Involvement of Behçet Syndrome
  • Abstract Number: 0044
    Aberrant Mevalonate Metabolite Farnesyl Pyrophosphate-Induced Neutrophil Hyperactivation in Behçet’s Disease Pathogenesis
  • Abstract Number: 1714
    Aberrant Myeloid Populations in the TNF-Transgenic Model of Pulmonary Hypertension Overexpress Interferon Pathways and Are Driven by TNFR1 Signaling
  • Abstract Number: 0651
    Abnormal Nailfold Video-capillaroscopy Is Independently Associated with non-UIP Radiographic Patterns in Autoimmune ILD: A Multicenter Study from the NEREA Registry
  • Abstract Number: 1893
    Abnormalities Detected with [18F]-FDG-PET/CT Imaging in VEXAS Syndrome
  • Abstract Number: 1129
    Accuracy and Performance Characteristics of Administrative Codes for the Diagnosis of Autoinflammatory Syndromes: A Discovery and Validation Study
  • Abstract Number: 0298
    Accuracy of the 2017 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) Classification Criteria and Myositis-Specific Autoantibodies-Based Classification Criteria for Classifying Patients with Idiopathic Inflammatory Myopathy
  • Abstract Number: 2575
    Accurate Stratification of Cancer Risk in a Real-World Cohort Using the International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening
  • Abstract Number: 2434
    Acetylated Bacterial Proteins as Potent Antigens Inducing an Anti-modified Protein Antibody Response
  • Abstract Number: 2239
    Achievement of Disease Control in PsA Patients Treated with Upadacitinib at Week 152: Post Hoc Analysis of the Long-term Extensions of Two Phase 3 Trials
  • Abstract Number: 1400
    Achieving ASDAS Inactive Disease Status in Axial Spondyloarthritis: A Systematic Review and Meta-analysis
  • Abstract Number: 1737
    ACPA, Anti-CarP and AAPA Can Be Detected in Saliva, but Not in Feces of Seropositive Rheumatoid Arthritis Patients – Support for Mucosal Involvement in Specific Locations in RA
  • Abstract Number: 0374
    Actionable Adverse Events in a Real-Practice Cohort of Children with Juvenile Idiopathic Arthritis. Results from the CAPRI Registry
  • Abstract Number: 1458
    Activated Naïve DNA-Reactive B Cells in Lupus Nephritis Patients Are Increased and Associated with Disease Activity
  • Abstract Number: 0070
    Activation of Joint CD8+ TRM Localize Autoantibody Mediated Arthritis
  • Abstract Number: 0882
    Activation of Ovarian Cancer G-Protein Coupled Receptor (OGR1) Attenuates Chondrocytes Inflammation via ERK1/2 Signaling Pathways in an in Vitro Model of Osteoarthritis
  • Abstract Number: 0366
    Active Joint Acoustic Emissions on the Achilles Tendon: A Digital Biomarker of Enthesitis Related Arthritis
  • Abstract Number: 1292
    Active Rheumatoid Arthritis Patients Exhibit an Altered Serum Lipidomic Profile Directly Linked to Disease Activity, Which Is Reversed by Biologic and Targeted Synthetic DMARD
  • Abstract Number: 0257
    Activity of IgG4-related Disease Differs Depending on the Presence or Absence of Concomitant Hypocomplementemia
  • Abstract Number: 0474
    Acute Cardiovascular Events During Pregnancy and Delivery in Patients with Autoimmune Rheumatic Diseases (ARDs): An Analysis of National Inpatient Sample
  • Abstract Number: 0722
    Acute Cardiovascular Events in Autoimmune Rheumatic Disease Pregnancies
  • Abstract Number: 1527
    Acute Effects of Intravenous Iloprost on Finger Power Doppler Ultrasound in Scleroderma Patients
  • Abstract Number: 0269
    Acute Kidney Injury and Plasma Cell-Rich Acute Interstitial Nephritis in VEXAS Syndrome: An Under-recognized Disease Feature
  • Abstract Number: 1753
    Acylcarnitine Enrichment Is a Characteristic of Rheumatoid Arthritis Fibroblast-Like Synoviocyte Metabolic Fingerprint
  • Abstract Number: 1336
    Adalimumab and Etanercept Serum Levels in Rheumatoid Arthritis Patients with and Without a Disease Flare During Tapering
  • Abstract Number: 2090
    Adaptation of the Making it WorkTM for People with Systemic Sclerosis
  • Abstract Number: 0169
    Added Value of Anti-HMGCR and Anti-SRP Antibodies in the Diagnosis of Immune Mediated Necrotizing Myopathy: An Outcome and Cost Comparison from the USA Perspective
  • Abstract Number: 0816
    Additive Association of ABCG2 rs4148155 and SLC22A12 rs75786299 Polymorphisms with Hyperuricemia, Gout and Nephrolithiasis, a Hospital-Based, Case-Control Study
  • Abstract Number: 2455
    Addressing Native American Health Disparities in Rheumatoid Arthritis by Training Primary Care Providers: Expanding the Reach of the RAE Initiative
  • Abstract Number: 0028
    Adenosine Deaminase 2 Is Expressed as a Short Isoform Lacking Deaminase Activity in the Endothelium: Implications for DADA2 Vasculitis
  • Abstract Number: 2142
    Adherence Patterns in Rheumatoid Arthritis Patients Receiving a Janus Kinase (JAK) Inhibitor or a Tumor Necrosis Factor α Inhibitor (TNFi) After the Addition of a Black Box Warning to JAK Inhibitors
  • Abstract Number: 0238
    Adherence to the Gout and Crystal Arthritis Network (G-CAN) Consensus Statements for Gout Nomenclature
  • Abstract Number: 1686
    Adolescent and Young Adult Rheumatology Patient Reports of Reproductive Health Screening and Counseling in the Clinical Setting
  • Abstract Number: 0367
    Adolescents and Young Adults Taking Methotrexate: Knowledge and Behaviours
  • Abstract Number: 1010
    Advanced Clinician Practitioners in Arthritis Care: A Workforce Profile
  • Abstract Number: 0187
    Advancing Health Equity with Lupus Stakeholders to Close Care Gaps and Disparities
  • Abstract Number: 0362
    Adverse Childhood Experiences Are Associated with Disease Outcomes in Youth with Juvenile Idiopathic Arthritis
  • Abstract Number: 1241
    Adverse Childhood Experiences in a Paediatric Systemic Lupus Erythematosus Cohort
  • Abstract Number: 0741
    Adverse Events Among Patients with and Without Autoimmune Rheumatic Disease Prescribed SGLT2 Inhibitors
  • Abstract Number: 0464
    Adverse Pregnancy Outcomes in Sjogren’s Disease Compared to Controls: An Interdisciplinary Approach with Maternal Fetal Medicine
  • Abstract Number: 1395
    Aerobic Capacity and Its Relation to Disease Characteristics and Lifestyle Habits in Patients with Axial Spondyloarthritis
  • Abstract Number: 2146
    After JAK Inhibitor Failure, “Switching” or “Cycling”?
  • Abstract Number: 2272
    Age and Race-Based Differences in Emergency Department Utilization for Systemic Lupus Erythematosus in the United States
  • Abstract Number: 2457
    Ageism in Rheumatology: The Health Care Professional’s Perspective
  • Abstract Number: 1242
    Agreement Between Parent- and Self-Report of Executive Function in Adolescents with Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 1810
    Alcohol Consumption Amount, Type of Beverage, and Gender, All Matters to Serum Uric Acid Levels
  • Abstract Number: 2491
    Alignment Between the Novel 2022 ACR/EULAR Classification Criteria for ANCA-associated Vasculitis (AAV), Clinical Diagnosis and Organ Manifestations in a European AAV Cohort
  • Abstract Number: 1169
    All-cause Mortality and Risk Factors for Death in a Large Multi-center Prospective Registry Cohort of Idiopathic Inflammatory Myositis in China
  • Abstract Number: 0069
    All-trans Retinoic Acid (atRA) Enhances FoxP3 Protein Stability Under Inflammatory Conditions Through Altering the FoxP3 Protein-interactome
  • Abstract Number: 0363
    Allogenic Hematopoietic Stem Cell Transplant for Children with Refractory Systemic Juvenile Idiopathic Arthritis and sJIA-Associated Lung Disease: 6-month Post-Transplant Outcomes from an International Cohort
  • Abstract Number: 0697
    Alterations in Composition and Function of Gut Microbiota in Patients with Large-Vessel Vasculitis
  • Abstract Number: 0018
    Alternative Splicing and Expected Protein Changes in Muscle Biopsies from Different Types of Idiopathic Inflammatory Myopathies
  • Abstract Number: 2329
    AMTX-100, a Nuclear Transport Inhibitor, Attenuates Inflammatory Cytokine Production in vitro and Following UV Mediated Skin Inflammation in a Mouse Model of Cutaneous Lupus Erythematosus in vivo
  • Abstract Number: 2041
    An Analysis of Recurrent Parotitis Patients Referred to Rheumatology Clinic
  • Abstract Number: 1729
    An Antibody-drug Conjugate of Anti-TNFα Antibody and a Novel Glucocorticoid Molecule Exerts Synergistic Anti-inflammatory Effects for Treatment of Autoimmune Diseases
  • Abstract Number: 0764
    An Atypical ClassRheum: RheumMadness, a Collaborative Rheumatology Competition Building Knowledge and Community
  • Abstract Number: 2323
    An Electronic Health Record-Based Algorithm for Predicting Systemic Lupus Erythematosus Flares: Integrating Clinical Factors and Social Determinants of Health
  • Abstract Number: 2567
    An Extended Interval Between mRNA COVID-19 Booster Vaccinations Is Associated with an Increased Humoral Immune Response in Patients with Inflammatory Rheumatic Diseases
  • Abstract Number: 1020
    An Increase in Safety Outcome Trials and the Issue of Informed Consent
  • Abstract Number: L13
    An Open-label, Multicenter, Phase 1/2 Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323, a Rapid Manufacturing CAR-T Cell Therapy Targeting CD19 on B Cells, for Severe Refractory Systemic Lupus Erythematosus: Preliminary Results
  • Abstract Number: 1735
    An Unorthodox HLA-DRhiCD15+ ‘Hybrid’ Population in Rheumatoid Arthritis Characterized Using Spectral Cytometry
  • Abstract Number: 1929
    Anakinra Treatment in Idiopathic Recurrent Pericarditis: A Single-center Experience
  • Abstract Number: L01
    Analysis of 245,388 Diverse Participants in the NIH All of Us Cohort Identifies VEXAS Resiliency in UBA1 M41L Somatic Mutation Carriers
  • Abstract Number: 0677
    Analysis of Clinical Outcomes in Eosinophilic Granulomatosis with Polyangiitis (EGPA) Treated with Mepolizumab over 2 Years for Remission Induction or Maintenance: A Single Center Experience in Japan
  • Abstract Number: 1933
    Analysis of IgG4-Related Disease in a Diverse Long Island Population: Insights from the Rheumatology Clinic
  • Abstract Number: 0577
    Analysis of Intracytoplasmic Toll – Like Receptors (TLRs) and MyD88 Expression in B Cell Subsets in Patients with Lupus Nephritis
  • Abstract Number: 1409
    Analysis of Soluble Biomarkers in Axial Spondyloarthritis
  • Abstract Number: 1577
    Analysis of Takayasu’s Arteritis as Risk Factor for Acute Coronary Syndrome
  • Abstract Number: 0202
    Analysis of the Effects of Immunosuppressive Therapy on Herpes Zoster Events After Each of Three Doses of the BNT162b2 mRNA Vaccine in Patients with Spondyloarthritis (SpA)
  • Abstract Number: 0500
    Analysis of the Probability of Retention of Golimumab as a Two-phase Exponential Decay Curve in Rheumatoid Arthritis or Spondyloarthropathies to Identify Patients with Higher Probability of Long-term Retention
  • Abstract Number: 0158
    Analyzing User Log Data to Track Provider Use of an EHR-based Dashboard for Rheumatoid Arthritis Outcomes
  • Abstract Number: 2381
    ANCA-associated Vasculitis and Renal Disease in a Multidisciplinary Outpatient Clinic in Northern Spain
  • Abstract Number: 1534
    ANCA-associated Vasculitis Incidence in a Norther Spanish Health Region
  • Abstract Number: 1715
    Androgen Treatment Exhibits a Protective Role Against Focal Erosions in TNF-Induced Inflammatory Arthritis in Mice
  • Abstract Number: 2477
    Anifrolumab Normalizes the Type I Interferon Signature in a Cohort of Patients with Type I Interferonopathies
  • Abstract Number: 0333
    Ankylosing Spondylitis Patient Perspective on Living with Flares and Impact on Quality of Life
  • Abstract Number: 0166
    Annual Economic Burden for Patients with Familial Hypophosphatemia in the United States
  • Abstract Number: 0277
    Anti-carbamylated Antibodies in Autoimmunity – Focus on Their Diagnostic and Prognostic Value: A Systematic Review and Meta-analysis
  • Abstract Number: 0050
    Anti-Citrullinated Histone Antibody CIT-013, a Dual Action Therapeutic for Neutrophil Extracellular Trap Associated Autoimmune Disease
  • Abstract Number: 2193
    Anti-citrullinated Protein Antibodies in Sjögren’s Syndrome Define a Subset of Patients with Lower B Cell Activation Markers and Higher Risk of Lung Involvement
  • Abstract Number: 1077
    Anti-drug Antibodies Formation During Tapering and Stopping of Methotrexate in Rheumatoid Arthritis Patients with Longstanding Use of Adalimumab
  • Abstract Number: 0934
    Anti-fibrotic Effects of MT-5562, a Novel Potent Selective Autotaxin Inhibitor, in Preclinical Studies: Roles of Lysophosphatidic Acid in Autoimmune Diseases and Clues to Treat Skin and Lung Fibrosis in Systemic Sclerosis
  • Abstract Number: 1177
    Anti-HMGCR Autoantibody Levels in the Follow-up of Statin-induced Immune-mediated Necrotizing Myopathy: Multicentric Study of 24 Patients
  • Abstract Number: 1174
    Anti-HMGCR Immune-mediated Necrotising Myopathy: Calculation of Incidence and Confirmation of Low Malignancy Risk in Two Independent Cohorts. a Retrospective Case Review
  • Abstract Number: 2546
    Anti-infliximab Antibodies as a Marker of Drug Survival and Tapering in Ankylosing Spondylitis Patients: 12 Years Follow-up
  • Abstract Number: 1931
    Anti-Ku Antibodies: A Case Series
  • Abstract Number: 1952
    Anti-MDA5 Associated Dermatomyositis: Clinical Features and Outcomes in a Predominantly African-American Case Series
  • Abstract Number: 1163
    Anti-melanoma Differentiation Associated Gene 5 (Anti-MDA5) Antibody Dermatomyositis: Clinical Features and Outcome in a Racially Diverse Patient Cohort
  • Abstract Number: 1961
    Anti-PM/Scl Autoantibodies in Juvenile Myositis Are Associated with a Distinct Phenotype Resembling Anti-synthetase Syndrome
  • Abstract Number: 2283
    Anti-SARS-CoV-2 Vaccination Among Patients Living with Systemic Lupus Erythematosus in Sweden: Coverage and Clinical Effectiveness
  • Abstract Number: 0068
    Anti-TNFR2 VHH Agonistic Antibodies Promote and Stabilize Treg Immunosuppressive Activity
  • Abstract Number: 0963
    Anti-Topoisomerase Antibody in dcSSc: Unravelling Its Intracellular Effects in Systemic Sclerosis
  • Abstract Number: 2210
    Antibodies to Four Novel Peptides in New Onset Axial Spondyloarthritis
  • Abstract Number: 1160
    Antibody Predictors of Prognosis in a Large Multi-centre Cohort of Idiopathic Inflammatory Myopathy Associated Interstitial Lung Disease
  • Abstract Number: 1764
    Antibody Responses to Citrullinated Type II Collagen and Vimentin Modified with Malondialdehyde-Acetaldehyde Differ in Rheumatoid Arthritis and Rheumatoid Arthritis-Interstitial Lung Disease
  • Abstract Number: 1467
    Antiphospholipid Antibodies and the Risk of Diffuse Alveolar Hemorrhage in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
  • Abstract Number: 0603
    Antiphospholipid Antibodies as Potential Predictors of Disease Severity and Poor Prognosis in Systemic Lupus Erythematosus Associated Thrombocytopeinia
  • Abstract Number: 1062
    Antiretinal Autoantibodies in Hydroxychloroquine Eye Toxicity
  • Abstract Number: 2558
    Aortic Aneurysms in a Multicenter Cohort of 196 Patients with Aortitis Related to Giant Cell Arteritis Treated with Tocilizumab
  • Abstract Number: 1645
    Aortic Dilatation and PET/CT Vascular Activity at Diagnosis and 5 Years in an Inception Giant Cell Arteritis (GCA) Cohort
  • Abstract Number: 0706
    Aortitis and Periaortitis Spectrum in 135 Patients from a Single Referral Centre
  • Abstract Number: 1235
    Apparent Diffusion Coefficient (ADC) from Diffusion Weighted Imaging (DWI) as an Objective Tool to Differentiate Normal Maturational Subchondral Signal from Inflammation at the Sacroiliac Joint in Youth
  • Abstract Number: 2400
    Applanation Tonometry of the Temporal Arteries in Participants with Suspected Giant Cell Arteritis: A Proof of Concept
  • Abstract Number: 1576
    Application of the 2022 ACR/EULAR Criteria for Takayasu Arteritis to Previously Diagnosed Patients Based on the 1990 ACR Criteria
  • Abstract Number: 0638
    Application of the 2022 European Society of Cardiology (ESC) Risk Assessment Model in Australian and Singaporean Systemic Sclerosis Patients with Newly Diagnosed Pulmonary Arterial Hypertension (PAH)
  • Abstract Number: 0463
    Appropriate Preconception Care Improves Pregnancy Outcomes in SLE Patients
  • Abstract Number: 1690
    Apremilast Reduces Inflammation as Measured by MRI of the Hand in Patients with Psoriatic Arthritis: Primary Results from the Phase 4 MOSAIC Study
  • Abstract Number: 1112
    AR882, a Potent Uricosuric Agent, Shows Favorable Uric Acid Excretion Profile Following Multiple Doses
  • Abstract Number: L15
    AR882, an Efficacious and Selective URAT1 Inhibitor for Patients with Chronic Gouty Arthritis and Subcutaneous Tophi: Results from a Global, Prospective, Proof-of-Concept Trial Using Dual Energy Computed Tomography
  • Abstract Number: 2303
    Are Neuropsychiatric Symptoms in Systemic Lupus Erythematosus (NPSLE) Associated with More Frequent Hospitalizations or Exposure to a Greater Number of Immunosuppressive Medications?
  • Abstract Number: 2574
    Are Patients Classified as IPAF More Likely to Also Meet SLE Criteria by 2019 EULAR/ACR Than by SLICC?: An Abstract
  • Abstract Number: 1844
    Are Patients with Inflammatory Rheumatic Diseases Ready for Studies with Medical Cannabis? – Results from a Digital Survey
  • Abstract Number: 1371
    Are Ultrasound Salivary Parenchymal Abnormalities More Severe in Primary Sjögren Patients with a Higher Disease Duration ? A Cross-sectional International Study
  • Abstract Number: 0491
    Arthralgia with Risk of Progression to Psoriatic Arthritis in a Large Cohort of Patients: Role of Ultrasound
  • Abstract Number: 0151
    Arthritis: A Wealth Gap
  • Abstract Number: 2136
    Arthritogenic Cells Found in the Peripheral Blood of Rheumatoid Arthritis Patients Transfer the Disease to NSG-DR4 Mice
  • Abstract Number: 1727
    Arthritogenicity of Homocitrullinated Peptides in HLA-DRB1 Transgenic Mice
  • Abstract Number: 1919
    Arthroplasty Outcomes in Immune Checkpoint Inhibitor-Treated Patients: A Single Center Series
  • Abstract Number: 1879
    Artificial Intelligence for the Detection of Sacroiliitis on Magnetic Resonance Imaging in Patients with Axial Spondyloarthritis
  • Abstract Number: 0745
    Artificial Intelligence Models for Computer-Assisted Joint Detection and Sharp-van Der Heijde Score Prediction in Hand Radiographs from Patients with Rheumatoid Arthritis
  • Abstract Number: 0195
    Assessing Cardiovascular Risk in Black and Latino Patients with Systemic Lupus Erythematosus
  • Abstract Number: 0780
    Assessing Differential Effects of DMARDs on Psoriasis Area and Severity Index and Patient Global Assessment in Subgroups of Patients with Active PsA Treated over 52-weeks with Secukinumab in a Non-Interventional Trial (AQUILA) Using a Multistage Clustering Approach
  • Abstract Number: 1903
    Assessing Disparities Through Missing Race and Ethnicity Data: Results from a Juvenile Arthritis Registry
  • Abstract Number: 1813
    Assessing Immunogenicity of SARS-CoV-2 Vaccine Neoantigen S1 in Autoimmune Rheumatic Disease Patients: A Study on Cellular and Humoral Responses
  • Abstract Number: 2315
    Assessing Lupus Disease Activity Following the Onset of End-Stage Kidney Disease Within a Single Tertiary Centre in South London
  • Abstract Number: 0371
    Assessing Methotrexate Adherence in JIA Using Electronic Health Record-Linked Pharmacy Dispensing Data
  • Abstract Number: 1210
    Assessing Patient-Reported Drug Efficacy and Adherence Among IL-23 Inhibitors for Psoriasis and Psoriatic Arthritis
  • Abstract Number: 0162
    Assessing Reproductive Health Counseling and Provider Attitudes in Rheumatology Post Roe v. Wade in Houston, Texas
  • Abstract Number: 2037
    Assessing Risk of Depression in Common Rheumatologic Disorders Using Diagnostic Codes, Survey Scores, and Propensity Score Matching Methodology
  • Abstract Number: 0043
    Assessing the Ability of Human Dental Pulp Stem Cells to Modulate the Macrophages Phenotype
  • Abstract Number: 1870
    Assessing the Appropriateness of Imaging Modalities in Primary Care for Low Back Pain and Their Impact on Outcomes: A Retrospective Observational Study in a Single Center in Trenton
  • Abstract Number: 0342
    Assessing the Known-group Validity of the IDEOM MSK-Q Using Data from the National Psoriasis Foundation Annual Survey
  • Abstract Number: 0985
    Assessing the Value of Comorbidity Clusters in Predicting Clinical Outcomes in Rheumatoid Arthritis: A Machine Learning Approach Using a Very Large US Registry
  • Abstract Number: 1246
    Assessment and Outcomes of 63 Cases of Juvenile Dermatomyositis-Associated Calcinosis
  • Abstract Number: 2452
    Assessment of Association Between Hydroxychloroquine Use and Toxic Retinopathy, Overall and by Indication, in a Large Cohort of Rheumatology Patients Within the US Department of Defense Military Healthcare System
  • Abstract Number: 0326
    Assessment of Depression in Ankylosing Spondylitis Using Center for Epidemiologic Studies Depression Scale
  • Abstract Number: 0509
    Assessment of Direct and Indirect Impact on Pain and Fatigue Outcomes in a Phase 2 Clinical Trial of Deucravacitinib, a Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Patients with Active PsA: A Mediation Analysis
  • Abstract Number: 1900
    Assessment of Hospitalist Confidence Levels in Management of Rheumatic Conditions to Identify Potential Knowledge Gaps
  • Abstract Number: 0748
    Assessment of Myositis-related Interstitial Lung Disease by ⁶⁸ Ga-DATA.SA.FAPi PET/CT
  • Abstract Number: 0508
    Assessment of Pain Outcomes in a Phase 2 Trial of a Selective, Allosteric Tyrosine Kinase 2 Inhibitor, Deucravacitinib, in Patients with Active PsA
  • Abstract Number: 0331
    Assessment of Patient Adherence to “Sick Day Rules”: A Cross-sectional Study of Rheumatology Outpatients Prescribed Immunosuppressive Medications
  • Abstract Number: 0661
    Assessment of Systemic Sclerosis-Associated Myocarditis: A Single Center Case Series Study
  • Abstract Number: 1567
    Assessment of the Extent and Accrual of Damage in Takayasu’s Arteritis
  • Abstract Number: 2034
    Assessment of the Immediate and Short-term Impact of an Information Course on Patients’ Knowledge About Rheumatoid Arthritis: Evaluation Using a Self-prepared and Validated Assessment Questionnaire
  • Abstract Number: 0188
    Association Between Area Deprivation Index and Organ Damage Accumulation in a Statewide Incident Lupus Cohort
  • Abstract Number: 1065
    Association Between COVID-19 and Disease-Modifying Antirheumatic Drugs
  • Abstract Number: 0983
    Association Between Disease-modifying Anti-rheumatic Drugs and Short-term Outcomes of Dengue: A Population-based, Cohort Study
  • Abstract Number: 2296
    Association Between EQ-5D-5L and SLEDAI Scores in Patients with Systemic Lupus Erythematosus in the United States and Europe: A Real-world Survey
  • Abstract Number: 2590
    Association Between Frailty and Readmissions in Hospitalized Patients with Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 2468
    Association Between Gut Microbiome-related Metabolites and Symptomatic Hand Osteoarthritis in Two Independent Cohorts
  • Abstract Number: 2187
    Association Between Illness Perception, Anxiety and Depression State, Disease Activity and Glucocorticoid Therapy in Patients with Sjӧgren’s Syndrome
  • Abstract Number: 1798
    Association Between Knee Osteoarthritis and Mortality: A Serial Propensity Score-matched Cohort Study
  • Abstract Number: 1992
    Association Between Knee Osteoarthritis Pain and Concomitant Drug Use: A Post-hoc Analysis of Two Phase 3 Clinical Trials
  • Abstract Number: 0992
    Association Between Metabolic Syndrome and the Presence of Enthesophytes on Musculoskeletal Ultrasound Compared to Joint X-ray
  • Abstract Number: 0438
    Association Between Methotrexate Use and Lymphoma in Rheumatoid Arthritis: A Systematic Literature Review
  • Abstract Number: 1137
    Association Between Nailfold Videocapillaroscopy Findings and sKL-6 Levels in Patients with Idiopathic Inflammatory Myopathies–Related Interstitial Lung Disease
  • Abstract Number: 0416
    Association Between Sleep Disorders and Rheumatoid Arthritis: A Population-based Cohort Study
  • Abstract Number: 0653
    Association Between Systemic Sclerosis and Increased Risk of Ischemic Stroke: A Meta-Analysis
  • Abstract Number: 1647
    Association Between Vascular FDG Uptake at Diagnosis and Evolution in Aortic Dimensions in Giant Cell Arteritis: A Prospective Study
  • Abstract Number: 0334
    Association of a Self-Report Screening Tool for Sarcopenia (SARC-F) with Functional Status Outcomes in Systemic Lupus Erythematosus
  • Abstract Number: 0414
    Association of a Treat-to-Target Management Approach with Physician and Patient Reported Outcomes Among Real – World Patients with Rheumatoid Arthritis Receiving Advanced Therapy in Europe
  • Abstract Number: 0908
    Association of Biologic Sex with Glycosphingolipids and the N-glycome in Lupus Nephritis and Renal Mesangial Cell Function
  • Abstract Number: 1672
    Association of COVID-19 Vaccinations with Flares of Systemic Rheumatic Disease: A Case-Crossover Study
  • Abstract Number: 1199
    Association of Dipeptidyl Peptidase-4 Inhibitor Use for Type 2 Diabetes and Incidence of OA in Taiwan
  • Abstract Number: 1448
    Association of Disease Activity and Anti-Double Stranded DNA Antibodies Titers with Echocardiographic Parameters in Systemic Lupus Erythematosus Patients
  • Abstract Number: 1488
    Association of Glucocorticoid Use with Patient-Reported Outcomes Among Persons with Systemic Lupus Erythematosus
  • Abstract Number: 1019
    Association of Historical Redlining and Present-Day Neighborhood Inequities with Missed Outpatient Appointments Among Individuals with Rheumatic Conditions
  • Abstract Number: 0130
    Association of HLA-DRB1 Alleles with Coronary Artery Calcium, Abdominal Aortic Calcium, and Carotid Intima-media Thickness in a Multi-ethnic Community-living Population
  • Abstract Number: 0975
    Association of HLA-DRB1 Alleles with Ischemic Events and Mortality in a Multi-ethnic Community-living Population
  • Abstract Number: 0027
    Association of HLA-DRB1 and ANKRD55/IL6ST Regions with Polymyalgia Rheumatica Diagnosis: A Genome Wide Association Study from UK Biobank and FinnGen
  • Abstract Number: 0696
    Association of Large-vessel Vasculitis with Inflammatory Bowel Diseases: A European Case-control Study
  • Abstract Number: 2096
    Association of Left Ventricular Mass with Interleukin-17 in Rheumatoid Arthritis Patients Without Clinical Heart Failure
  • Abstract Number: 1196
    Association of Long-Term Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) with Worsening Symptoms and Structural Changes of Knee Osteoarthritis: An Individual Patient Data Meta-Analysis of Cohort Studies
  • Abstract Number: 1359
    Association of Menstrual Cycles and Disease Flare Activity in Women with Systemic Lupus Erythematosus and Rheumatoid Arthritis
  • Abstract Number: 2290
    Association of Mycophenolate and Azathioprine Use with Cognitive Function in Systemic Lupus Using a Bayesian Longitudinal Item-response Theory Model
  • Abstract Number: 1799
    Association of Pregabalin vs Gabapentin with Incident Congestive Heart Failure in Patients with Non-Cancer Pain
  • Abstract Number: 2194
    Association of Self-perceived Oral Health Status with ESSPRI Reported by Sjögren’s Syndrome Patients
  • Abstract Number: 1461
    Association of Serum Analytes with SLE Cognitive Impairment Phenotypes Formed by Machine Learning: MMP-9, S100A8/A9, IL-6, IL-10, and NGAL
  • Abstract Number: 0990
    Association of Treatment and Disease Activity with Antibiotic Use and Hospitalized Infection Among People Living with Rheumatoid Arthritis: Baseline Data from a Longitudinal Study in the ArthritisPower Registry
  • Abstract Number: 2222
    Association Spondyloarthritis and Inflammatory Bowel Disease, More Severe Diseases on Both Sides
  • Abstract Number: 0420
    Associations and Mortality Impact of Machine Learning-derived Quantitative Computed Tomography Parenchymal Lung Features in Rheumatoid Arthritis and non-RA Comparators in a Multicenter Prospective Cohort of Smokers
  • Abstract Number: 1474
    Associations and Outcomes of Critical Peripheral Ischemia in Systemic Lupus Erythematosus (SLE): Data from Indian SLE Inception Cohort for Research (INSPIRE)
  • Abstract Number: 2469
    Associations Between Body Composition Measurements of Obesity and the Radiographic Progression of Hand Osteoarthritis: Data from the Dong-gu Study
  • Abstract Number: 2127
    Associations Between Rheumatoid Arthritis, Frailty Status and Mortality in Older Adults with Bladder Cancer
  • Abstract Number: 1609
    Associations Between SARS-Cov-2 Infection and Neuropathic Pain in Fibromyalgia Patients: A Cohort Study
  • Abstract Number: 2139
    Associations of Adipocytokines with Cancer Incidence in a Prospective Rheumatoid Arthritis Cohort
  • Abstract Number: 0227
    Associations of DMARDs with Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases: A Prospective Study
  • Abstract Number: 1763
    Asthma Severity Is Associated Increased Serum Anti-cyclic Antibody Level at Baseline and in Increase During Longitudinal Follow-up
  • Abstract Number: 0536
    Asynchronous Tele Consultation by WhatsApp Chatbot in Controlled Axial Spondyloartrhitis Patients Under Biological Therapy: Patients Perspective
  • Abstract Number: 0537
    Asynchronous Teleconsultation by WhatsApp Chatbot in Controlled Axial Spondyloartrhitis Patients Under Biological Therapy as a More Sustainable Model Than Face-to-face Classical Consultation
  • Abstract Number: 1283
    Atherogenic Index of Plasma Identifies Patients with Rheumatoid Arthritis and Increased Carotid Intima-Media Thickness
  • Abstract Number: 0943
    Attenuation of Fibroblast Activation and Fibrosis by Adropin in a Hedgehog-Dependent Manner
  • Abstract Number: 2070
    Augmenting Medical Education: An Evaluation of GPT-4 and ChatGPT in Answering Rheumatology Questions from the Spanish Medical Licensing Examination
  • Abstract Number: 0544
    Autoantibodies to dsDNA and Associated Proteins: Association with Proteinuria and Lupus Nephritis
  • Abstract Number: 2134
    Autoantibodies to Joint-related Proteins Predict Remission with High Specificity in New Onset RA
  • Abstract Number: 1607
    Autoantibodies to Transcription Factor a Mitochondria Link Mitochondrial Damage and Thrombosis in Systemic Lupus Erythematosus
  • Abstract Number: 2572
    Autoantibody Profile of Autoimmune Driven Interstitial Lung Disease as Compared to Idiopathic Pulmonary Fibrosis and Association of Autoantibodies with Survival
  • Abstract Number: 2510
    Autoantibody-positivity Before Treatment Is Associated with Immune-related Adverse Events in Melanoma Patients Treated with anti-PD-1
  • Abstract Number: 1590
    Autoimmune Pathway Blockade by a Potent Orally Bioavailable STING Antagonist
  • Abstract Number: 1192
    Autoimmune Thyroid Disease Associates with Symptomatic Hand Osteoarthritis in Older Persons in the Third National Health and Nutrition Examination Survey
  • Abstract Number: 0402
    Automated Detection and Quantification of Hand Joint Swelling in Rheumatoid Arthritis: Computer Vision, Deep Neural Network Models, and a Potential Biomarker for Disease Activity Monitoring
  • Abstract Number: 0481
    Automatically Detect Finger Joint Center and Angle on Hand X-ray: A Deep Learning Model
  • Abstract Number: 1706
    Autoreactive B Cell Responses Are Enriched in Early-onset Oligoarticular Juvenile Idiopathic Arthritis
  • Abstract Number: 0687
    Avacopan for the Treatment of ANCA-associated Vasculitis. Real World Experience in Spain
  • Abstract Number: 0682
    Avacopan in ANCA-associated Vasculitis Received Intensified Induction Therapy with Cyclophosphamide Plus Rituximab – Retrospective Case Serial of 12 Patients
  • Abstract Number: 2208
    Awareness and Attitudes Regarding Axial Spondyloarthritis Among Non-Rheumatology Physicians in the United States
  • Abstract Number: 0493
    Axial Disease Activity in Psoriatic Arthritis Is Higher in Patients with Carotid Plaque
  • Abstract Number: 1555
    Axial Spondyloarthritis in Patients with Gastrointestinal Involvement of Behçet Syndrome
  • Abstract Number: 0492
    Axial Spondyloarthritis in Patients with Late-Onset Chronic Low Back Pain (Older Than 45 Years). Axial Spa or Psoriatic Disease with Axial Involvement?
  • Abstract Number: 0889
    Axl Receptor Tyrosine Kinase Ameliorates Pristane Induced Diffuse Alveolar Hemorrhage in Mice by Regulating Macrophage Polarization
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology